Difference between revisions of "Serimmune antibody analysis results"
(adding new results from post-covid sample) |
|||
| Line 25: | Line 25: | ||
==Post-exposure responses== | ==Post-exposure responses== | ||
| − | + | [[File:Before_and_after_covid_antibody_results.png|alt=image of results before and after covid infection|thumb|Serimmune results before and after natural covid infection in a previously-vaccinated individual.]] | |
| + | |||
| + | {| class="wikitable" | ||
| + | |- | ||
| + | ! Individual !! Date !! Report !! Notes | ||
| + | |- | ||
| + | | [[ User:Madprime]] || 2022-05-27 || [[File:TOEAIX_20220527.pdf]] || Covid positive on 2022-05-01. Previously vaccinated with booster. | ||
| + | |} | ||
= Other results= | = Other results= | ||
| Line 40: | Line 47: | ||
|- | |- | ||
| [[User:Igerg]] || 2022-04-13 || [[File:EXACZL_Additional_20220413.pdf]] || Tested for Lyme several times, all negative | | [[User:Igerg]] || 2022-04-13 || [[File:EXACZL_Additional_20220413.pdf]] || Tested for Lyme several times, all negative | ||
| + | |- | ||
| + | | [[User:Madprime]] || 2022-05-27 || [[File:TOEAIX_Additional_20220527.pdf]] || | ||
|} | |} | ||
Revision as of 23:07, 1 July 2022
The Serimmune COVID-19 Study is a longitudinal research study conducted by the Serimmune company. The study uses the company's "Serum Epitope Repertoire Analysis (SERA) technology" to study antibody responses, especially in the context of COVID-19 vaccination and exposure.
The study returns research-grade results (not intended for diagnostic clinical use) to participants. As described in the study consent document, these results are not clinically validated and not meant to serve as a clinical assay. They are, nevertheless, interesting to look at!
The study is planned to last five years, with blood samples collected every six months. Samples are self-collected by participants using a home collection kit and sent by mail.
Project Infobox 
| |
|---|---|
| Self researcher(s) | User:Madprime, User:Sprague |
| Related tools | |
| Related topics | |
Builds on project(s) |
|
| Has inspired | Projects (0) |
SARS-CoV-2 Antibody Analyses
Vaccine-only responses
| Individual | Date | Report | Notes |
|---|---|---|---|
| User:Madprime | 2022-02-03 | File:TOEAIX 20220203.pdf | Moderna vaccine (two shots, plus booster) |
| User:Sprague | 2021-12-14 | File:RichardSpragueSerimmuneCOVID 20211214.pdf | Pfizer vaccine (two shots, no booster) |
| User:Igerg | 2022-04-13 | File:EXACZL 20220413.pdf | Moderna vaccine (two shots, plus booster) - chronic spontaneous urticaria following booster |
Post-exposure responses
| Individual | Date | Report | Notes |
|---|---|---|---|
| User:Madprime | 2022-05-27 | File:TOEAIX 20220527.pdf | Covid positive on 2022-05-01. Previously vaccinated with booster. |
Other results
In addition to COVID-19 related antibody analyses, the study shares research analysis of antibodies related to infectious diseases (Lyme Disease, Ehrlichiosis, Anaplasmosis, Babesiosis, Chagas Disease) and autoimmune conditions (Celiac Disease).
| Individual | Date | Report | Notes |
|---|---|---|---|
| User:Madprime | 2022-02-03 | File:TOEAIX Expanded 20220203.pdf | No medical history related to these analyses. |
| User:Sprague | 2022-12-14 | File:RichardSpragueSerimmune 20211214.pdf | |
| User:Igerg | 2022-04-13 | File:EXACZL Additional 20220413.pdf | Tested for Lyme several times, all negative |
| User:Madprime | 2022-05-27 | File:TOEAIX Additional 20220527.pdf |
Linked content on this wiki
(The content in the table below is automatically created. See Template:Project Queries for details. If newly linked pages do not appear here, click on "More" and "Refresh".)
| Project that build on this project |
|---|
| We talked about this project in the following meetings |
|---|
| 2022-05-26 Self-Research Chat, 2022-06-02 Self-Research Chat, 2022-07-14 Self-Research Chat, 2022-09-15 Self-Research Chat, 2022-12-29 Self-Research Chat |